Publications by authors named "Jordan-Vu Ha"

Alzheimer's disease (AD), the most common age-related neurodegenerative disorder, is currently conceptualized as a disease of synaptic failure. Synaptic impairments are robust within the AD brain and better correlate with dementia severity when compared with other pathological features of the disease. Nevertheless, the series of events that promote synaptic failure still remain under debate, as potential triggers such as β-amyloid (Aβ) can vary in size, configuration and cellular location, challenging data interpretation in causation studies.

View Article and Find Full Text PDF
Article Synopsis
  • Defects in interleukin-1β (IL-1β) responses are linked to Alzheimer's disease (AD) pathology.
  • Researchers investigated the role of TOM1, a negative regulator of IL-1R1, finding its levels decreased in both AD-affected human brains and a mouse model.
  • Manipulating TOM1 levels altered microglia activity, increased amyloid-beta, and impacted cognition, suggesting TOM1 may be a key target for future AD therapies.
View Article and Find Full Text PDF